아시아태평양의 인터벤션 이미징 시장 : 분석 및 예측(2023-2033년)

Asia-Pacific Interventional Imaging Market: Analysis and Forecast, 2023-2033

US $ 2,950 ￦ 4,086,000

PDF and Excel (1-3 User License)

PDF 및 Excel 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,450 ￦ 6,164,000

PDF and Excel (Global License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

아시아태평양의 인터벤션 이미징 시장 규모는 2023년 11억 1,000만 달러로 평가되며, 2023년부터 2033년까지 예측 기간 동안 8.18%의 연평균 복합 성장률(CAGR)로 성장해 2033년 말에는 24억 4,000만 달러에 달할 것으로 예상됩니다.

이러한 확대는 최소침습적 시술에 대한 수요 증가, 신기술 사용 증가, 만성질환의 확산에 기인하는 것으로 보입니다. 이 시장에는 만성 질환의 진단 및 치료를 위해 설계된 다양한 기술, 소모품, 시스템 및 소프트웨어가 포함됩니다.

주요 시장 통계
예측 기간	2023년-2033년
2023년 평가	11억 1,000만 달러
2033년 전망	24억 4,000만 달러
CAGR	8.18%

아태 지역의 인터벤션 이미징 시장은 특히 의료 진단 및 치료 분야에서 이미징 시스템의 발전에 필수적인 역할을 하고 있습니다. 인터벤션 이미징은 정확한 진단과 질병의 조기 발견을 가능하게 합니다. 이러한 조기 발견은 치료 결과와 환자 예후를 개선합니다. 인터벤션 이미징 기술은 치료와 발견을 혁신적으로 변화시켜 획기적인 발전을 가져왔으며, 앞으로의 발전이 기대되는 기술입니다.

이 보고서는 아시아태평양의 인터벤션 이미징(Interventional Imaging) 시장을 조사했으며, 시장 개요와 함께 제품별/용도별/최종 사용자별/국가별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

주요 요약

조사 방법

제1장 시장

제2장 인터벤셔널 이미징 시장 : 개요

• 시장 서론
• 시장 규모와 성장 가능성, 10억 달러, 2022년-2033년
• 업계 인터벤셔널 이미징 현재와 향후 상황

제3장 업계 전망

• 주요 동향
• 특허 분석
  • 특허 분석(연별)
  • 특허 분석(국가별)
• COVID-19의 인터벤셔널 이미징 시장에 대한 영향
• 규제 요건
• 제품 벤치마킹

제4장 인터벤셔널 이미징 시장 역학

• 영향 분석
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회

제5장 인터벤셔널 이미징 시장(지역별),(10억 달러), 2022년-2033년

• 개요
• 아시아태평양
  • 시장 규모와 예측
  • 일본
  • 중국
  • 호주
  • 한국
  • 인도
  • 싱가포르
  • 기타 지역

제6장 기업 개요

• 인터벤셔널 이미징 에코시스템의 활약 기업

LSH

영문 목차

영문목차

“The Asia-Pacific Interventional Imaging Market Expected to Reach $2.44 Billion by 2033.”

Introduction to Asia-Pacific (APAC) Interventional Imaging Market

The Asia-Pacific interventional imaging market was valued at $1.11 billion in 2023 and is expected to reach $2.44 billion by the end of 2033, growing at a CAGR of 8.18% during the forecast period 2023-2033. This expansion can be ascribed to rising demand for minimally invasive procedures, as well as increased use of new technology and the prevalence of chronic conditions. The market encompasses a variety of techniques, consumables, systems, and software designed for chronic disease diagnosis and treatment.

KEY MARKET STATISTICS
Forecast Period	2023 - 2033
2023 Evaluation	$1.11 Billion
2033 Forecast	$2.44 Billion
CAGR	8.18%

Market Introduction

The Asia-Pacific interventional imaging market is critical to the evolution of imaging systems, especially in medical diagnostics and therapy. It allows for accurate diagnosis and early disease identification. This early discovery improves treatment outcomes and the prognosis of patients. Interventional imaging technology has transformed therapy and detection, resulting in breakthroughs and promised future developments.

Market Segmentation:

Segmentation 1: by Offering

• Interventional Imaging Systems
• Interventional Imaging Software
• Consumables

Segmentation 2: by Application

• Cardiology
• Neurology
• Musculoskeletal
• Oncology
• Urology
• Gastroenterology
• Obstetrics
• Gynaecology
• Others

Segmentation 3: by End User

• Hospitals
• Ambulatory Surgical Centres
• Clinics

Segmentation 4: by Country

• Japan
• China
• India
• Australia
• South Korea
• Singapore
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific interventional imaging market (by offering) has been segmented into detailed segments, including different types of interventional imaging systems, namely X-ray, CT scanners, MRI systems, and ultrasound imaging systems. Moreover, the study provides the reader with a detailed understanding of the different applications of these products.

Competitive Strategy: Key players in the Asia-Pacific interventional imaging market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific interventional imaging market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

Table of Contents

Executive Summary

Research Methodology

1. Markets

• 1.1. Product Definition
• 1.2. Inclusion and Exclusion
• 1.3. Key Findings

2. Interventional Imaging Market: Overview

• 2.1. Market Introduction
• 2.2. Market Footprint and Growth Potential, $Billion, 2022-2033
• 2.3. Current and Future State of Interventional Imaging in Industry

3. Industry Outlook

• 3.1. Key Trends
• 3.2. Patent Analysis
  • 3.2.1. Patent Analysis (by Year)
  • 3.2.2. Patent Analysis (by Country)
• 3.3. COVID-19 Impact on Interventional Imaging Market
  • 3.3.1. COVID-19 Impact: Current Scenario of the Market
  • 3.3.2. Pre- and During-COVID-19 Impact Assessment
    • 3.3.2.1. Pre-COVID-19
    • 3.3.2.2. During-COVID-19
• 3.4. Regulatory Requirements
  • 3.4.1. Regulatory and Legal Requirements and Framework in the U.S.
  • 3.4.2. Regulatory and Legal Requirements and Framework in Europe
  • 3.4.3. Regulatory and Legal Requirements and Framework in Asia-Pacific
    • 3.4.3.1. China
    • 3.4.3.2. Japan
    • 3.4.3.3. India
    • 3.4.3.4. Australia
• 3.5. Product Benchmarking

4. Interventional Imaging Market Dynamics

• 4.1. Impact Analysis
• 4.2. Market Drivers
  • 4.2.1. Increasing Demand for Minimally Invasive Surgical Procedures
  • 4.2.2. Technological Advancements in Surgical Procedures and Imaging Technologies
    • 4.2.2.1. Rising Adoption of 4K Imaging Technologies
    • 4.2.2.2. 3D and 4D Imaging
  • 4.2.3. Upsurge in Incidence of Chronic Diseases Leading to Growth in the Adoption of Interventional Imaging
    • 4.2.3.1. Cardiovascular Diseases
    • 4.2.3.2. Cancer
  • 4.2.4. Increasing Adoption of Inorganic Growth Strategies in the Market
• 4.3. Market Restraints
  • 4.3.1. Shortages of Skilled Professionals
  • 4.3.2. Restrictive Reimbursement Landscape
  • 4.3.3. High Cost of Interventional Imaging Systems
• 4.4. Market Opportunities
  • 4.4.1. Integration of AI in Interventional Imaging
  • 4.4.2. Collaboration with Hospitals, Clinics, and Other Healthcare Facilities for Development of Interventional Imaging Solutions

5. Interventional Imaging Market (by Region), ($Billion), 2022-2033

• 5.1. Overview
• 5.1. Asia-Pacific
  • 5.1.1. Market Sizing and Forecast
    • 5.1.1.1. Asia-Pacific Interventional Imaging Market (by Offering)
    • 5.1.1.2. Asia-Pacific Interventional Imaging Market (by Application)
    • 5.1.1.3. Asia-Pacific Interventional Imaging Market (by End User)
  • 5.1.2. Japan
    • 5.1.2.1. Market Sizing and Forecast
      • 5.1.2.1.1. Japan Interventional Imaging Market (by Offering)
      • 5.1.2.1.2. Japan Interventional Imaging Market (by Application)
      • 5.1.2.1.3. Japan Interventional Imaging Market (by End User)
  • 5.1.3. China
    • 5.1.3.1. Market Sizing and Forecast
      • 5.1.3.1.1. China Interventional Imaging Market (by Offering)
      • 5.1.3.1.2. China Interventional Imaging Market (by Application)
      • 5.1.3.1.3. China Interventional Imaging Market (by End User)
  • 5.1.4. Australia
    • 5.1.4.1. Market Sizing and Forecast
      • 5.1.4.1.1. Australia Interventional Imaging Market (by Offering)
      • 5.1.4.1.2. Australia Interventional Imaging Market (by Application)
      • 5.1.4.1.3. Australia Interventional Imaging Market (by End User)
  • 5.1.5. South Korea
    • 5.1.5.1. Market Sizing and Forecast
      • 5.1.5.1.1. South Korea Interventional Imaging Market (by Offering)
      • 5.1.5.1.2. South Korea Interventional Imaging Market (by Application)
      • 5.1.5.1.3. South Korea Interventional Imaging Market (by End User)
  • 5.1.6. India
    • 5.1.6.1. Market Sizing and Forecast
      • 5.1.6.1.1. India Interventional Imaging Market (by Offering)
      • 5.1.6.1.2. India Interventional Imaging Market (by Application)
      • 5.1.6.1.3. India Interventional Imaging Market (by End User)
  • 5.1.7. Singapore
    • 5.1.7.1. Market Sizing and Forecast
      • 5.1.7.1.1. Singapore Interventional Imaging Market (by Offering)
      • 5.1.7.1.2. Singapore Interventional Imaging Market (by Application)
      • 5.1.7.1.3. Singapore Interventional Imaging Market (by End User)
  • 5.1.8. Rest-of-Asia-Pacific
    • 5.1.8.1. Market Sizing and Forecast
      • 5.1.8.1.1. Rest-of-Asia-Pacific Interventional Imaging Market (by Offering)
      • 5.1.8.1.2. Rest-of-Asia-Pacific Interventional Imaging Market (by Application)
      • 5.1.8.1.3. Rest-of-Asia-Pacific Interventional Imaging Market (by End User)

6. Company Profiles

• 6.1. Interventional Imaging Ecosystem Active Players
  • 6.1.1. Canon Inc.
    • 6.1.1.1. Role of Canon Inc. in the Interventional Imaging Market
    • 6.1.1.2. Recent Developments
    • 6.1.1.3. Analyst Perspective
  • 6.1.2. FUJIFILM Holdings Corporation
    • 6.1.2.1. Role of FUJIFILM Holdings Corporation in the Interventional Imaging Market
    • 6.1.2.2. Analyst Perspective
  • 6.1.3. Shimadzu Corporation
    • 6.1.3.1. Role of Shimadzu Corporation in the Interventional Imaging Market
    • 6.1.3.2. Analyst Perspective
  • 6.1.4. Terumo Corporation
    • 6.1.4.1. Role of Terumo Corporation in the Interventional Imaging Market
    • 6.1.4.2. Analyst Perspective
    • 6.1.4.3. Analyst Perspective
  • 6.1.5. Trivitron Healthcare
    • 6.1.5.1. Role of Trivitron Healthcare in the Interventional Imaging Market
    • 6.1.5.2. Recent Developments
    • 6.1.5.3. Analyst Perspective

관련자료